AUPH - What's Going On With Aurinia Pharmaceuticals Stock? | Benzinga
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are trading higher, adding to gains of more than 17% over the last week. The stock has been trending higher since the company announced that its collaboration partner Otsuka Pharmaceutical filed a new drug application (NDA) at the beginning of last week.
What Happened: Otsuka Pharmaceutical, which Aurinia entered into a collaboration and licensing agreement with in 2020, filed an NDA for voclosporin for the treatment of lupus ...